
Biocon Limited has informed the Exchange regarding a press release dated November 07, 2020, titled "Biocon Biologics Receives USD 150 MillionCapital Injection from Goldman Sachs, Transaction Values Biocon Biologics at USD 3.94 Billion".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated November 07, 2020, titled "Biocon Biologics Receives USD 150 MillionCapital Injection from Goldman Sachs, Transaction Values Biocon Biologics at USD 3.94 Billion".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon